---
pmid: '37327784'
title: Gasdermin D licenses MHCII induction to maintain food tolerance in small intestine.
authors:
- He K
- Wan T
- Wang D
- Hu J
- Zhou T
- Tao W
- Wei Z
- Lu Q
- Zhou R
- Tian Z
- Flavell RA
- Zhu S
journal: Cell
year: '2023'
full_text_available: false
doi: 10.1016/j.cell.2023.05.027
---

# Gasdermin D licenses MHCII induction to maintain food tolerance in small intestine.
**Authors:** He K, Wan T, Wang D, Hu J, Zhou T, Tao W, Wei Z, Lu Q, Zhou R, Tian Z, Flavell RA, Zhu S
**Journal:** Cell (2023)
**DOI:** [10.1016/j.cell.2023.05.027](https://doi.org/10.1016/j.cell.2023.05.027)

## Abstract

1. Cell. 2023 Jul 6;186(14):3033-3048.e20. doi: 10.1016/j.cell.2023.05.027. Epub 
2023 Jun 15.

Gasdermin D licenses MHCII induction to maintain food tolerance in small 
intestine.

He K(1), Wan T(2), Wang D(2), Hu J(1), Zhou T(2), Tao W(2), Wei Z(3), Lu Q(3), 
Zhou R(4), Tian Z(4), Flavell RA(5), Zhu S(6).

Author information:
(1)Department of Digestive Disease, The First Affiliated Hospital of USTC, 
Division of Life Sciences and Medicine, University of Science and Technology of 
China, Hefei 230001, China; Institute of Immunology and the CAS Key Laboratory 
of Innate Immunity and Chronic Disease, Division of Life Sciences and Medicine, 
University of Science and Technology of China, Hefei 230027, China.
(2)Institute of Immunology and the CAS Key Laboratory of Innate Immunity and 
Chronic Disease, Division of Life Sciences and Medicine, University of Science 
and Technology of China, Hefei 230027, China.
(3)Department of Immunobiology, Yale University School of Medicine, New Haven, 
CT 06520, USA.
(4)Institute of Immunology and the CAS Key Laboratory of Innate Immunity and 
Chronic Disease, Division of Life Sciences and Medicine, University of Science 
and Technology of China, Hefei 230027, China; Institute of Health and Medicine, 
Hefei Comprehensive National Science Center, Hefei 230601, China.
(5)Department of Immunobiology, Yale University School of Medicine, New Haven, 
CT 06520, USA; Howard Hughes Medical Institute, Yale University School of 
Medicine, New Haven, CT 06520, USA. Electronic address: 
richard.flavell@yale.edu.
(6)Department of Digestive Disease, The First Affiliated Hospital of USTC, 
Division of Life Sciences and Medicine, University of Science and Technology of 
China, Hefei 230001, China; Institute of Immunology and the CAS Key Laboratory 
of Innate Immunity and Chronic Disease, Division of Life Sciences and Medicine, 
University of Science and Technology of China, Hefei 230027, China; Institute of 
Health and Medicine, Hefei Comprehensive National Science Center, Hefei 230601, 
China; School of Data Science, University of Science and Technology of China, 
Hefei 230026, China. Electronic address: zhushu@ustc.edu.cn.

Comment in
    Trends Immunol. 2023 Aug;44(8):571-573. doi: 10.1016/j.it.2023.06.006.
    Cell Res. 2023 Dec;33(12):896-897. doi: 10.1038/s41422-023-00856-6.
    Gastroenterology. 2023 Dec;165(6):1575. doi: 10.1053/j.gastro.2023.08.024.

The intestinal epithelial cells (IECs) constitute the primary barrier between 
host cells and numerous foreign antigens; it is unclear how IECs induce the 
protective immunity against pathogens while maintaining the immune tolerance to 
food. Here, we found IECs accumulate a less recognized 13-kD N-terminal fragment 
of GSDMD that is cleaved by caspase-3/7 in response to dietary antigens. Unlike 
the 30-kD GSDMD cleavage fragment that executes pyroptosis, the IEC-accumulated 
GSDMD cleavage fragment translocates to the nucleus and induces the 
transcription of CIITA and MHCII molecules, which in turn induces the Tr1 cells 
in upper small intestine. Mice treated with a caspase-3/7 inhibitor, mice with 
GSDMD mutation resistant to caspase-3/7 cleavage, mice with MHCII deficiency in 
IECs, and mice with Tr1 deficiency all displayed a disrupted food tolerance 
phenotype. Our study supports that differential cleavage of GSDMD can be 
understood as a regulatory hub controlling immunity versus tolerance in the 
small intestine.

Copyright Â© 2023. Published by Elsevier Inc.

DOI: 10.1016/j.cell.2023.05.027
PMID: 37327784 [Indexed for MEDLINE]

Conflict of interest statement: Declaration of interests S.Z. is a cofounder of 
Ibiome which studies microbial regulation of immune responses. R.A.F. is a 
cofounder of Ventus, which studies inflammatory pathways. Both in topics 
unrelated to the subject of this work.
